No, the relationship with Eisai started after Clarity AD had been planned and the tests for this trial were old school pencil &paper. However they are thought to be working on the Lecanemab subcutaneous trial and the cessation and maintenance regimen trials. It it also confirmed they worked on Lilly's Trailblazer Phase 3.
Ann: Industry News, page-5
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.5¢ |
Change
-0.035(3.76%) |
Mkt cap ! $154.4M | |||
| Open | High | Low | Value | Volume |
| 91.5¢ | 92.3¢ | 89.5¢ | $100.2K | 110.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1954 | 89.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 4777 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| CGS (ASX) Chart |